1
Total investments
0
Early stage
0
Mid stage
0
Late stage
8y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Project Investor
Feb 2018
23andMe, headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple FDA authorizations for genetic health risk reports. The company has created the world’s largest crowdsourced platform for genetic research, with 80 percent of its customers electing to participate. The 23andMe research platform has generated more than 180 publications on the genetic underpinnings of a wide range of diseases, conditions, and traits. The platform also powers the 23andMe Therapeutics group, currently pursuing drug discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory, and cardiovascular diseases, in addition to other therapeutic areas. 23andMe was named as one of the San Francisco Chronicles Top Workplaces and one of Comparablys Best Places to Work in 2022. CEO, Anne Wojcicki was also named one of Glassdoor’s top CEOs in 2019 and one of Comparably’s "Best CEOs for Women" in 2021 and 2022. More information is available at www.23andMe.com.
Experience · 4 entries
All (4)
Investments (1)
2018
Project Investor
Feb 2018
23andMe, headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple FDA authorizations for genetic health risk reports. The company has created the world’s largest crowdsourced platform for genetic research, with 80 percent of its customers electing to participate. The 23andMe research platform has generated more than 180 publications on the genetic underpinnings of a wide range of diseases, conditions, and traits. The platform also powers the 23andMe Therapeutics group, currently pursuing drug discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory, and cardiovascular diseases, in addition to other therapeutic areas. 23andMe was named as one of the San Francisco Chronicles Top Workplaces and one of Comparablys Best Places to Work in 2022. CEO, Anne Wojcicki was also named one of Glassdoor’s top CEOs in 2019 and one of Comparably’s "Best CEOs for Women" in 2021 and 2022. More information is available at www.23andMe.com.
Head of Compliance and Risk Management
2018
Menlo Park Capital is global venture capital, and consulting firm focused on breeding highly impact entrepreneurs in Europe, Canada, the United States, and emerging markets like Indonesia, Singapore, and India. Founded by Habib Imam in 2019, we make long-term, hands-on strategic investments in our chosen core areas: Climate tech, Deep tech, Robotics, Artificial intelligence, and Sustainability. We actively partner with a distinct set of companies, including early-stage startups building breakthrough technologies. Our team enjoys helping to frame strategic investments and help the companies to grow internationally.
We also support the execution of new strategies through a pragmatic, implementation-ready approach. With industry experts embedded into every project, our strategy execution is tailored to your industry.
2016
Client Relationship Director
2016
Sequoia helps daring founders build legendary companies from idea to IPO and beyond. We aim to be the first true believers in tomorrow’s most valuable and enduring businesses. We partner with a few outliers each year and go all-in, providing them with the hands-on help required at every stage of the company building journey. Our expertise comes from 50 years of working with legendary founders like Steve Jobs, Larry Page, Jan Koum, Adi Tatarko, Brian Chesky, Jensen Huang, Anne Wojcicki, Eric Yuan, Patrick Collison, Julia Hartz, and Sebastian Siemiatkowski. In aggregate, Sequoia-backed companies account for more than 25% of NASDAQs total value. Since our inception, the vast majority of the money we invest has been on behalf of nonprofits and schools like the Ford Foundation, Mayo Clinic and MIT, which means most of the returns we generate benefit these great causes.
2013
Private Equity Investment Partners
Dec 2013
Blackstone Group is a full-service custom marketing research and consulting firm providing clients with actionable insights for over 25 years.
Our unique proprietary methods are designed to provide maximum insight:
-SEQuaLS (customer satisfaction, loyalty and retention)
-Persona IPB (image positioning and branding)
-Namecraft (name generation and testing)
-SCAPE (new product development)
-Concept ESP (online early concept screening)
-(IQ)2 (online Interactive Insight from Qualitative/Quantitative)
-Custom longitudinal panels
-Chimeric (hybrid research)
Our team of 100+ research professionals and vast network of multilingual interviewers and moderators provide high quality research using state-of-the-art in-house resources:
-Web surveys (programming and hosting)
-Custom online dashboards
-Online focus groups
-40+ calling stations (CATI/CAWI)
-Predictive dialing
Our clients include leading organizations in a variety of industries, including: financial services, insurance, healthcare, CPG, not-for-profits/associations, pharmaceuticals, technology and utilities.
We are a certified minority-owned/diversity firm.
